Table 3.
Parameter | Placebo | CaP | Change |
---|---|---|---|
Energy | 9 ± 2 | 9 ± 2 | 013 ± 1 |
(MJ/day) | (7–9) | (9–10) | (−0.09–0.3) |
Fat | 84 ± 25 | 85 ± 27 | 0.7 ± 15 |
(g/day) | (79–90) | (79–91) | (−2–4) |
Protein | 82 ± 19 | 82 ± 19 | 0.3 ± 12 |
(g/day) | (78–86) | (78–86) | (−2–3) |
Carbohydrates | 265 ± 49 | 271 ± 56 | 5 ± 36 |
(g/day) | (255–276) | (259–282) | (−3–13) |
Calcium | 1069 ± 289 | 2088 * ± 314 | 1019 # ± 209 |
(mg/day) | (1009–1130) | (2022–2154) | (975–1063) |
Calcium | 16 ± 4 | 31 * ± 6 | 15 # ±4 |
(mg/kg bw.) | (15–17) | (30–32) | (14–16) |
Phosphorus | 1434 ± 315 | 1924 * ± 323 | 490 # ± 199 |
(mg/day) | (1368–1500) | (1857–1992) | (449–532) |
Phosphorus | 21 ± 4 | 28 * ± 5 | 7 # ± 3 |
(mg/kg bw.) | (20–22) | (27–29) | (7–8) |
n (studies) = 4; n (subjects) = 90; mean ± standard deviation; (95% confidence interval); CaP: three–four weeks’ intervention with Ca5(PO4)3OH (pentacalcium hydroxy-trisphosphate); bw body weight; * significantly different to placebo (paired Student’s t-test, p ≤ 0.05); # significantly different to zero (one-way ANOVA, p ≤ 0.05).